Austin W. Marxe & David M. Greenhouse’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$4.85M	Hold	450,000	–	–	0.66%	52
2014 Q2	$6.87M	Hold	450,000	–	–	0.87%	42
2014 Q1	$8.14M	Sell	450,000 -1,244,401	-73%	-$24M	0.9%	39
2013 Q4	$23.5M	Sell	1,694,401 -25,000	-1%	-$288K	2.52%	7
2013 Q3	$18M	Sell	1,719,401 -44,102	-3%	-$438K	2.21%	8
2013 Q2	$13.8M	Buy	+1,763,503	New	+$15.4M	1.86%	13

Other funds holding SGMO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's SGMO Position: Q3 2014 in Review

Austin W. Marxe & David M. Greenhouse held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q3 2014 at 450,000 shares worth $4.85M. The position accounts for 0.66% of the portfolio, ranked #52.

Austin W. Marxe & David M. Greenhouse first reported a position in SGMO in Q2 2013 and has held it in 6 quarters since. The position peaked at $23.5M in Q4 2013. 157 funds tracked by Wall St. Rank hold SGMO as of Q3 2014.

Austin W. Marxe & David M. Greenhouse held 450,000 shares of SANGAMO THERAPEUTICS INC worth $4.85M as of Q3 2014.
Austin W. Marxe & David M. Greenhouse left its SANGAMO THERAPEUTICS INC share count unchanged in Q3 2014.
SANGAMO THERAPEUTICS INC made up 0.66% of Austin W. Marxe & David M. Greenhouse's portfolio in Q3 2014, its #52 holding.
Austin W. Marxe & David M. Greenhouse first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 6 quarters since.
Austin W. Marxe & David M. Greenhouse's SANGAMO THERAPEUTICS INC position peaked at $23.5M in Q4 2013.
157 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2014, filed 14 Nov 2014.